4171 Stock Overview
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan.
GeneReach Biotechnology Corp. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$53.10|
|52 Week High||NT$171.82|
|52 Week Low||NT$50.10|
|1 Month Change||-37.13%|
|3 Month Change||-32.16%|
|1 Year Change||-38.89%|
|3 Year Change||45.07%|
|5 Year Change||167.26%|
|Change since IPO||43.17%|
Recent News & Updates
|4171||TW Medical Equipment||TW Market|
Return vs Industry: 4171 underperformed the TW Medical Equipment industry which returned -8.3% over the past year.
Return vs Market: 4171 underperformed the TW Market which returned -18% over the past year.
|4171 Average Weekly Movement||7.8%|
|Medical Equipment Industry Average Movement||5.4%|
|Market Average Movement||5.1%|
|10% most volatile stocks in TW Market||8.3%|
|10% least volatile stocks in TW Market||2.4%|
Stable Share Price: 4171 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 4171's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers pathogen detection platforms, including equipment and reagents; and animal use medicines, biotechnology services, medical materials and equipment, and precision instruments. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services.
GeneReach Biotechnology Corp. Fundamentals Summary
|4171 fundamental statistics|
Is 4171 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4171 income statement (TTM)|
|Cost of Revenue||NT$305.70m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||8.94|
|Net Profit Margin||38.65%|
How did 4171 perform over the long term?See historical performance and comparison